3 resultats
The authors continuously administered prostaglandin E1 (PGE1) iv to 2 infants with tetralogy of Fallot (TOF) and esophageal atresia with tracheoesophageal fistula (TEF) for more than 30 days, and observed side effects which could be attributed to the long-term administration of PGE1. After division
This is a report of a premature infant presenting with an esophageal atresia. At surgery it was realized that there was no posterior mediastinum and a single pleural cavity only. Other serious congenital anomalies were present. She died rather suddenly upon cessation of her prostaglandin E 1 at 34
The effect of associated congenital abnormalities, particularly cardiac malformations, on the survival rate of infants with esophageal atresia is emphasized in a number of publications. In infants with non-duct-dependent cardiac anomalies, repair of the esophagus takes precedence whereas in